Pacific Biosciences of California Inc
PACB
Get informed when a big investor buys or sells
+ FollowMarket Cap$462.8M
Close$
$5.61
254.9% upside
Current Fair Value
254.9% upsideUndervalued by 254.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $462.80 Million |
|---|---|
| Enterprise Value | $910.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.82 |
| Beta | 2.4 |
| Outstanding Shares | 305,819,000 |
Return
| Return on Equity | -5434.32% |
|---|---|
| Return on Assets | -16.43% |
| Return on Invested Capital | -21.01% |
Valuation & Multiples
| P/E Ratio | -3.54 |
|---|---|
| PEG | 3.61 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.69 |
| Enterprise Value to EBIT | -5.79 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.79 |
| Debt to Equity | 305.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 3, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$42.90 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1227▲ 76.68% |
|---|---|
| Total Calls | 574,800▼ 76.83% |
| Total Puts | 645,300▼ 26.89% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 62.33%▼ 4.40% |
|---|---|
| Total Invested | $248.53M▼ 33.47% |
| Investors Holding | 235▲ 10.00% |
ESG Score
No data